Search Results for "Benzodiazepine Multiple Sclerosis"

08:14 EDT 9th October 2015 | BioPortfolio

Matching Channels

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Systemic Sclerosis

Amyotrophic lateral sclerosis ALS

Diffuse mesangial sclerosis

B lymphocyte stimulator BlyS

Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.

Matching News

Benzodiazepines in Primary Care: Danger

Appropriate treatment of anxiety is of paramount importance in the primary care setting. Family practice providers are in a position to best understand each patient's background, resources and challen...

Phase III success in progressive multiple sclerosis

The last couple of decades have seen major progress in the treatment of relapsing-remitting multiple sclerosis (RRMS), with a number of drug approvals. In contrast, clinical trials of drug candidates ...

Drugs Lessen Multiple Sclerosis Damage in Mice

Drugs Lessen Multiple Sclerosis Damage in MiceIn a mouse study, 2 drugs already on the market activated stem cells and repaired the type of brain damage seen in multiple sclerosis. The finding might ...

Multiple sclerosis: Scientists identify cause of movement, balance problems

New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty 'brake' within immune cells, a brake that should be controlling the inflammation. This...

Multiple sclerosis: Scientists ID cause of movement, balance problems

(University of Virginia Health System) New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty 'brake' within immune cells, a brake that shoul...

Novartis Buys Rights to Multiple Sclerosis Drug from GlaxoSmithKline

Novartis is acquiring all the remaining rights to GlaxoSmithKline’s (GSK) multiple sclerosis (MS) drug, Ofatumumab. A fully human monoclonal antibody which targets the CD20 molecule, Ofatumumab ...

Intrathecal (IT) Administration of Rituximab to Treat Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a chronic, neurological, autoimmune, demyelinating disease. The pathology of MS is characterized by an abnormal immune response directed against the central nervous system....

Multiple Sclerosis Treatment Market Value to Reach $20 Billion by 2024

The value of the multiple sclerosis therapeutics market will rise slowly from $17.2 billion in 2014 to approximately $20 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 1.5%, according to ...

Matching PubMed Articles

Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.

Cognitive deficits are common in multiple sclerosis. Most previous studies investigating the imaging substrate of cognitive deficits in multiple sclerosis included patients with relatively short disea...

Genetic analysis of the isolated Faroe Islands reveals SORCS3 as a potential multiple sclerosis risk gene.

In search of the missing heritability in multiple sclerosis (MS), additional approaches adding to the genetic discoveries of large genome-wide association studies are warranted.

Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.

Cognitive impairment occurs from the early phases of multiple sclerosis (MS), and more frequently affects secondary progressive (SP) subjects than relapsing-remitting (RR).

Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.

There have been no clinical trials for approval of medications for treating multiple sclerosis in patients younger than age 18 years. All treatments are based on personal experience and data from ope...

Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.

Memory impairment is frequent in multiple sclerosis (MS), but it is unclear what functional brain changes underlie this cognitive deterioration.

Search Whole site using Google


Advertisement Advertisement